'Shortfall' in Array Business, Customer Delays Force Illumina to Cut Q2 Revenue Guidance | GenomeWeb

A "shortfall" in its array business has forced Illumina to cut its second-quarter revenue guidance by between 4 percent and 7 percent, or to approximately $161 million from between $168 million and $173 million, as previously forecast.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.